Evidence map›Paper›PMID 17410445›Full record

Trial reportDigestive diseases and sciences2007

Hepatitis C hypervariable region 1: association of reduced selection pressure in african americans with treatment failure.

Vicki M Park, Barbara C Mason, Julia Krushkal, Rongling Li, Caroline Riely, Jaquelyn Fleckenstein

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Digestive diseases and sciences, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Ethnic variations in chronic liver diseases.Digestive diseases and sciences · 2008
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vicki M ParkDepartment of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA. vpark@utmem.edu
Barbara C Mason
Julia Krushkal
Rongling Li
Caroline Riely
Jaquelyn Fleckenstein

Funding

USE OF MOTIVATIONAL INTERVIEWING TO MANAGE TYPE I DIABETESM01RR000211 · NCRR · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI DAGOGO-JACK, SAMUEL · 1985 to 2006
$9.6M
Surrogate HCV to study virus/cell interactionsU19AI048216 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI FLECKENSTEIN, JAQUELYN F · 2000 to 2004
$3.9M
NCRR NIH HHS M01 RR-00211NIAID NIH HHS U19 AI-48216
6 · The paper itself

Abstract

In a prospective therapeutic trial, features of the hepatitis C quasispecies were investigated as possible markers of therapeutic response. Individuals chronically infected with hepatitis C genotype 1 received antiviral therapy consisting of alpha-interferon plus ribavirin. The study targeted the most rapidly evolving segment of the viral genome, hypervariable region 1 within the envelope-2 gene. Among individuals failing to clear virus in response to therapy, significant differences were observed between quasispecies of African-American and Caucasian subjects. While distance measures for synonymous substitutions were similar between racial subgroups, measures of distance at the amino acid level (nonsynonymous substitutions) varied significantly. Taken together, the observed patterns of variability corresponded to reduced host selection pressure against hypervariable region 1 in African-American nonresponders. Reduced selection pressure was present at baseline and persisted through treatment and follow-up, suggesting population stratification of host factors that influence selection pressure on hepatitis C virus.

Indexed as

Black or African AmericanSelection, GeneticAdultAntiviral AgentsDrug CarriersFemaleFollow-Up StudiesGenotypeHepacivirusHepatitis C, ChronicHumansInterferon-alphaInterferon alpha-2MaleMiddle AgedPolyethylene GlycolsAntiviral AgentsDrug CarriersHVR1 protein, Hepatitis C virusInterferon-alphaInterferon alpha-2peginterferon alfa-2aPolyethylene GlycolsRecombinant ProteinsRibavirinRNA, ViralViral Proteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.